Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$222.44
-6.37%
Mkt Cap $14.73B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
Implied Upside
+44.0%
Consensus $320.36 vs current $222.44
NASDAQ·Healthcare·Biotechnology
$222.44
-6.37%
Mkt Cap $14.73B
Buy
5
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
+44.0%
Consensus $320.36 vs current $222.44